By Tony Mauro | June 14, 2017
Civil litigators and corporate counsel can almost taste victory in Bristol-Myers Squibb v. Superior Court of California, seen as the term's most important case on jurisdiction.
By Michael Booth | June 8, 2017
A federal judge has ordered a Pennsylvania doctor and her husband to pay Novartis Pharmaceuticals Corp. $1.87 million in fee sanctions and counterclaim damages in a discrimination lawsuit that was deemed to have been lodged in bad faith.
By njlawjournal | New Jersey Law Journal | June 5, 2017
The Legal Department at Sanofi U.S. has provided valuable pro bono services in recent years, including 2016, largely through its work with Pro Bono Partnership.…
By Robert Storace | May 17, 2017
The prescription drug company denied allegations that it falsely billed Medicaid and Medicare while agreeing to the settlement.
By Charles Toutant | May 3, 2017
AstraZeneca Pharmaceuticals and Bristol-Myers Squibb were hit with 14 suits in the District of New Jersey on Tuesday claiming that users of diabetes drug saxagliptin face elevated risks of heart failure as a result of using the drug.
By Amanda Bronstad | May 3, 2017
Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. and Bayer brought in powerhouse litigator Beth Wilkinson of Washington, D.C.'s Wilkinson Walsh + Eskovitz to lead the defense team in the first of four bellwether trials.
By Charles Toutant | May 2, 2017
A state appeals court tossed a $25 million verdict against Hoffmann-La Roche in a suit over acne drug Accutane after finding that the trial judge improperly restricted duplicative testimony from two defense experts.
By Jason Grant | May 1, 2017
A federal judge in Massachusetts ruled Manhattan plaintiffs firm Milberg "implemented an elaborate scheme of misrepresentation and deceit under the guise of a legitimate medical research study" and dismissed a plaintiff's qui tam action.
By P.J. D'Annunzio | May 1, 2017
There will be no second chance for a dismissed False Claims Act case pursued by a whistleblower and numerous government entities alleging that Genentech suppressed data about Avastin, a federal appeals court has decided.
By Charles Toutant | April 26, 2017
Already under scrutiny from lawmakers over pricing of its EpiPen epinephrine injector, Mylan faces new lawsuits from consumers and a competitor in New Jersey federal courts accusing it of taking anti-competitive actions to protect its product's market share.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS